133 related articles for article (PubMed ID: 2904311)
1. Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.
Echizen H; Shoda R; Umeda N; Ishizaki T
Clin Pharmacol Ther; 1988 Dec; 44(6):690-8. PubMed ID: 2904311
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
[TBL] [Abstract][Full Text] [Related]
3. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
[TBL] [Abstract][Full Text] [Related]
4. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
5. Suppression of gastric acid secretion by intravenous administration of famotidine in children.
Treem WR; Davis PM; Hyams JS
J Pediatr; 1991 May; 118(5):812-6. PubMed ID: 2019939
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Famotidine in gastric acidity, plasma secretin and gastrin in duodenal ulcer patients. With reference to 24-hour intragastric pH monitoring].
Shiratori K; Watanabe S; Maruyama M; Itoh Y; Adachi H; Kurokawa K; Takeuchi T
Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):855-63. PubMed ID: 6146733
[No Abstract] [Full Text] [Related]
7. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of famotidine in children.
James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
[TBL] [Abstract][Full Text] [Related]
11. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
13. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
Ostro MJ
Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
[TBL] [Abstract][Full Text] [Related]
15. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Lanzon-Miller S; Pounder RE; Ball SG; Dalgleish DJ; Coward J; Jackson AO
Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of famotidine: a summary.
Chremos AN
J Clin Gastroenterol; 1987; 9 Suppl 2():7-12. PubMed ID: 2887616
[TBL] [Abstract][Full Text] [Related]
17. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
Morgan MY; Stambuk D
Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
[TBL] [Abstract][Full Text] [Related]
18. Nizatidine suppression of basal gastric acid output: a comparison of two intravenous dosage regimens.
Danziger L; Furmaga KM; Rodvold KA; Bombeck CT; Fischer JH
J Clin Pharmacol; 1989 Oct; 29(10):946-52. PubMed ID: 2574190
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of famotidine in man.
Kroemer H; Klotz U
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):458-63. PubMed ID: 2888738
[TBL] [Abstract][Full Text] [Related]
20. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
Bachmann K; Sullivan TJ; Jauregui L
J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
